Plus therapeutics reports q3 earnings per share $0.03

Plus therapeutics reports third quarter 2019 financial and business results.q3 earnings per share $0.03 from continuing operations.q3 2019 contract revenues were $4.8 million, compared to $0.5 million for q3 2018.ended quarter with approximately $16.8 million of cash and cash equivalents.
PSTV Ratings Summary
PSTV Quant Ranking